Latest News


September 4, 2018

Macrolide Pharmaceuticals Expands Leadership and Strengthens Expertise in Drug Development, Clinical Strategy, Finance and Business Development  Full Press Release Here

April 2, 2018

Macrolide Pharmaceuticals Appoints New President and CEO, Raises $20 Million in Investor Financing  Full Press Release Here

March 26, 2018

Macrolide Pharmaceuticals Announces Up to $6.8 Million from CARB-X to Develop Macrolide Antibiotics with Gram-Negative Activity  Full Press Release Here

March 15, 2018

Macrolide Pharmaceuticals Presents New Data on Tool to Differentiate Macrolide Antibacterial Drug by Risk of Liver Toxicity  Full Press Release Here


October 5, 2017


Macrolide Pharmaceuticals Appoints Two New Board Members. Full Press Release Here


October 24, 2016


Andrew Myers research is discussed in the Harvard Magazine article Super Drugs for Super Bugs.


June 9, 2016

Macrolide Pharmaceuticals was featured this month in Biocentury Innovations article “Building A Better Haystack”, by Selina Koch.


May 24, 2016

Macrolide Pharmaceuticals Scientific Founder Publishes New Findings in Nature About Groundbreaking Technology for Novel Macrolide Antibiotics.


May 28, 2015

Macrolide was featured this month in AAAS magazine Science article “The Drug Push – fighting drug resistant bacteria”.


March 4, 2015

Macrolide Pharmaceuticals, Inc. Raises $22 Million in Series A Financing.